Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine

Indoleamine 2,3-dioxygenase (IDO) expression in dendritic cells (DCs) inhibits T-cell activation and promotes T-cell differentiation into regulatory T-cells. Moreover, IDO expression promotes resistance to immunotherapies targeting immune checkpoints such as the cytotoxic T lymphocyte antigen-4 (CTL...

Descripción completa

Detalles Bibliográficos
Autores principales: Sioud, Mouldy, Nyakas, Marta, Sæbøe-Larssen, Stein, Mobergslien, Anne, Aamdal, Steinar, Kvalheim, Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967686/
https://www.ncbi.nlm.nih.gov/pubmed/27504122
http://dx.doi.org/10.1155/2016/9639585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967686/
https://www.ncbi.nlm.nih.gov/pubmed/27504122
http://dx.doi.org/10.1155/2016/9639585

Ejemplares similares